Aquestive therapeutics stock

Published by ifjkg tsrjthu
22/05/2023

Aquestive therapeutics stock By Katryna Perera. Law360 (March 15, 2023, 10:17 PM EDT) -- A New Jersey federal judge has dismissed for now a proposed investor class action against Aquestive Therapeutics Inc. that accused the pharmaceutical company and its executives of making false and misleading statements about the likelihood of the U.S. Food and Drug Administration approving one of its new drug applications.Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.Aquestive Therapeutics Inc is around the top of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver.AQST received an overall …May 19, 2023 · What is Aquestive Therapeutics Inc’s stock style? AQST’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ...25mpfomcdonalds mankato Description. Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic ...May 15, 2023 · Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... Aquestive Therapeutics Inc. 2.17. Delayed Data. As of May 19. +0.16 / +7.96%. Today’s Change. 0.62. Today ||| 52-Week Range. 2.65.May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. About Aquestive Therapeutics Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide ... addy's sandwich bar A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Aquestive Therapeutics share dividends. We're not expecting Aquestive Therapeutics to pay a dividend over the next 12 months. Aquestive Therapeutics share price volatility. Over the last 12 months, Aquestive Therapeutics's shares have ranged in value from as little as $0.618 up to $2.399. A popular way to gauge a stock's volatility is its "beta".May 15, 2023 · Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.May 19, 2023 · A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. mesh rhinestone dress Miguel Garrison. May 9, 2023. Companies. Aquestive Therapeutics Inc. (NASDAQ:AQST) traded at $2.25 at close of the session on Monday, 05/08/23, made an upward move of 10.29% on its previous day’s price. Looking at the stock we see that its previous close was $2.04 with the day’s price range being $2.1296 – $2.40.May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. By Katryna Perera. Law360 (March 15, 2023, 10:17 PM EDT) -- A New Jersey federal judge has dismissed for now a proposed investor class action against Aquestive Therapeutics Inc. that accused the pharmaceutical company and its executives of making false and misleading statements about the likelihood of the U.S. Food and Drug Administration approving one of its new drug applications.What's Happening With Aquestive Therapeutics Inc Stock Today? Aquestive Therapeutics Inc (AQST) stock is trading at $2.44 as of 2:14 PM on Monday, May 22, an increase of $0.27, or 12.44% from the previous closing price of $2.17. The stock has traded between $2.15 and $2.45 so far today. Volume today is more active than usual. crumbl cookies redding SIMPLEX TRADING LLC Bought 1.2 Thousand shares of Aquestive Therapeutics In... Top 10 Owners of Aquestive Therapeutics Inc ... Vanguard Total Stock Market ETF: 1.46%: 790,992: 901,731: 0: 0.00% ...2 days ago · Aquestive Therapeutics shares surged 6.7% in their trading debut Wednesday, after the company priced its initial public offering at $15 a share, the midpoint of its price range of $14 to $16. Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of -9.52% and 7.57%, respectively, for the quarter ended December 2022. Do the …Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... gc pho Aquestive Therapeutics Inc (AQST) stock is trading at $2.44 as of 2:14 PM on Monday, May 22, an increase of $0.27, or 12.44% from the previous closing price of $2.17. The stock has traded between $2.15 and $2.45 so far today. Volume today is more active than usual. So far 849,475 shares have traded compared to average volume of …The latest price target for Aquestive Therapeutics ( NASDAQ: AQST) was reported by Wedbush on Thursday, March 9, 2023. The analyst firm set a price target for 4.00 expecting AQST to rise to within ...Aquestive Therapeutics, Inc. Common Stock (AQST) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Aquestive Therapeutics, Inc. (AQST) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Add to watchlist. 2.0400 +0.0800 (+4.08%) At close: 04:00PM EDT. 2.0500 …View Aquestive Therapeutics, Inc AQST investment & stock information. Get the latest Aquestive Therapeutics, Inc AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Aquestive Therapeutics, Inc. (AQST) NasdaqGM - NasdaqGM Real Time Price. Currency in USD. Add to watchlist. 2.0400 +0.0800 (+4.08%) At close: 04:00PM EDT. 2.0500 …May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. pecado bueno WARREN, N.J., June 08, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients’ problems with current standards of care and provide transformative products to improve their lives, today announced that it has closed its previously announced …Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ...May 19, 2023 · A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Discover historical prices for AQST stock on Yahoo Finance. View daily, weekly or monthly format back to when Aquestive Therapeutics, Inc. stock was issued. Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ...What's Happening With Aquestive Therapeutics Inc Stock Today? Aquestive Therapeutics Inc (AQST) stock has fallen -4.72% while the S&P 500 is up 0.72% as of 12:38 PM on Wednesday, May 17. AQST has fallen -$0.10 from the previous closing price of $2.10 on volume of 402,790 shares. Over the past year the S&P 500 has risen 1.24% while AQST is up 65 ... sabaidee lao crumbl cookie nashville Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... gelabongMay 15, 2023 · Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... Aquestive Therapeutics doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of ...May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. About the Aquestive Therapeutics Inc stock forecast. As of 2023 May 02, Tuesday current price of AQST stock is 1.405$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Aquestive Therapeutics stock price has been showing a declining tendency so we believe that similar market segments were …A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. y2k hello kitty Discover historical prices for AQST stock on Yahoo Finance. View daily, weekly or monthly format back to when Aquestive Therapeutics, Inc. stock was issued.Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of 210% and 9.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock ...What's Happening With Aquestive Therapeutics Inc Stock Today? Aquestive Therapeutics Inc (AQST) stock is trading at $2.44 as of 2:14 PM on Monday, May 22, an increase of $0.27, or 12.44% from the previous closing price of $2.17. The stock has traded between $2.15 and $2.45 so far today. Volume today is more active than usual.May 15, 2023 · Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... May 19, 2023 · A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. View Aquestive Therapeutics, Inc AQST investment & stock information. Get the latest Aquestive Therapeutics, Inc AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Aquestive Therapeutics stock was originally listed at a price of $16.05 in Jul 25, 2018. If you had invested in Aquestive Therapeutics stock at $16.05, your return over the last 4 years would have been -87.23%, for an annualized return of -40.22% (not including any dividends or dividend reinvestments).May 19, 2023 · A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. brooklyn suyaWhat is Aquestive Therapeutics Inc’s stock style? AQST’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns.Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.Aquestive Therapeutics Inc (AQST) stock is trading at $2.38 as of 3:43 PM on Tuesday, May 23, a drop of -$0.03, or -1.25% from the previous closing price of $2.41. Volume today is high. So far 958,719 shares have traded compared to average volume of 698,928 shares. The stock has traded between $2.35 and $2.69 so far today.Discover historical prices for AQST stock on Yahoo Finance. View daily, weekly or monthly format back to when Aquestive Therapeutics, Inc. stock was issued. May 15, 2023 · Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... nyse f news Description. Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic ...Tunatura. Shares of Aquestive Therapeutics ( NASDAQ: AQST) have fallen by over 90% since their $67.5M IPO was priced at $15 in 2018. So far in 2022, the company has lost two-thirds of its value ...Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a …Aquestive Therapeutics Inc ( AQST) is up 7.61% today. AQST has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on AQST! AQST stock closed at $1.97 and is up $0.15 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between ...Aquestive Therapeutics doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of ...May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. May 15, 2023 · Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... Aquestive Therapeutics, Inc. Common Stock (AQST) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Aquestive Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in developing orally administered products to deliver molecules, providing alternatives to care therapies. The Company has also developed a product pipeline focused on treating diseases of the central nervous system (CNS).Discover historical prices for AQST stock on Yahoo Finance. View daily, weekly or monthly format back to when Aquestive Therapeutics, Inc. stock was issued.Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ...By Katryna Perera. Law360 (March 15, 2023, 10:17 PM EDT) -- A New Jersey federal judge has dismissed for now a proposed investor class action against Aquestive Therapeutics Inc. that accused the pharmaceutical company and its executives of making false and misleading statements about the likelihood of the U.S. Food and Drug Administration approving one of its new drug applications.By Katryna Perera. Law360 (March 15, 2023, 10:17 PM EDT) -- A New Jersey federal judge has dismissed for now a proposed investor class action against Aquestive Therapeutics Inc. that accused the pharmaceutical company and its executives of making false and misleading statements about the likelihood of the U.S. Food and Drug Administration approving one of its new drug applications.May 15, 2023 · Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives. We are developing orally administered products to deliver complex molecules, providing novel alternatives to … us stock market holidays What is Aquestive Therapeutics Inc’s stock style? AQST’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns.2 days ago · View Aquestive Therapeutics, Inc AQST investment & stock information. Get the latest Aquestive Therapeutics, Inc AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. What is Aquestive Therapeutics Inc’s stock style? AQST’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. schw iron hill menu aguachiles near meAquestive Therapeutics shares surged 6.7% in their trading debut Wednesday, after the company priced its initial public offering at $15 a share, the midpoint of its price …Viracta Therapeutics Inc (VIRX) stock is up 10.49% while the S&P 500 is lower by -0.23% as of 3:14 PM on Friday, May 19. VIRX is up $0.20 from the previous closing price of $1.93 on volume of 1,354,358 shares. Over the past year the S&P 500 has risen 7.38% while VIRX is up 2.90%. VIRX lost -$1.34 per share the over the last 12 months. Click ...May 19, 2023 · A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Aquestive Therapeutics Inc (AQST) stock has fallen -4.72% while the S&P 500 is up 0.72% as of 12:38 PM on Wednesday, May 17. AQST has fallen -$0.10 from the previous closing price of $2.10 on volume of 402,790 shares. Over the past year the S&P 500 has risen 1.24% while AQST is up 65.29%. AQST lost -$0.71 per share the over the last 12 months.Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients’ therapeutic problems. Its product pipeline include …Apr 7, 2021 · Aquestive Therapeutics is a world leader in oral film drug delivery with its PharmFilm technology. Its lead product candidate, Libervant, is moving closer to NDA resubmission by the Q2 end. wacc meaning May 19, 2023 · What is Aquestive Therapeutics Inc’s stock style? AQST’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. What's Happening With Aquestive Therapeutics Inc Stock Today? Aquestive Therapeutics Inc (AQST) stock is trading at $2.44 as of 2:14 PM on Monday, May 22, an increase of $0.27, or 12.44% from the previous closing price of $2.17. The stock has traded between $2.15 and $2.45 so far today. Volume today is more active than usual.Tunatura. Shares of Aquestive Therapeutics ( NASDAQ: AQST) have fallen by over 90% since their $67.5M IPO was priced at $15 in 2018. So far in 2022, the company has lost two-thirds of its value ...May 15, 2023 · Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... oasis diner Discover historical prices for AQST stock on Yahoo Finance. View daily, weekly or monthly format back to when Aquestive Therapeutics, Inc. stock was issued. wingstop galveston Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of 210% and 9.48%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... store capital stock zona cantina + cocinaAquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives. We are developing orally administered products to deliver complex molecules, providing novel alternatives to … franconia pizza May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. Volume today is high. So far 958,719 shares have traded compared to average volume of 698,928 shares. The stock has traded between $2.35 and $2.69 so far today. More About Aquestive Therapeutics Inc Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical ...View Aquestive Therapeutics, Inc AQST investment & stock information. Get the latest Aquestive Therapeutics, Inc AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.May 19, 2023 · What is Aquestive Therapeutics Inc’s stock style? AQST’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns. Aquestive Therapeutics Inc stock price live 2.280, this page displays NASDAQ AQST stock exchange data. View the AQST premarket stock price ahead of the market … a como esta dolar By Katryna Perera. Law360 (March 15, 2023, 10:17 PM EDT) -- A New Jersey federal judge has dismissed for now a proposed investor class action against Aquestive Therapeutics Inc. that accused the pharmaceutical company and its executives of making false and misleading statements about the likelihood of the U.S. Food and Drug Administration approving one of its new drug applications.May 19, 2023 · Viracta Therapeutics Inc (VIRX) stock is up 10.49% while the S&P 500 is lower by -0.23% as of 3:14 PM on Friday, May 19. VIRX is up $0.20 from the previous closing price of $1.93 on volume of 1,354,358 shares. Over the past year the S&P 500 has risen 7.38% while VIRX is up 2.90%. VIRX lost -$1.34 per share the over the last 12 months. Click ... May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. Aquestive is a pharmaceutical company aiming to solve patients’ problems by advancing current standards of care through simplifying complex delivery methods. Aquestive is developing orally administered products to provide novel alternatives to invasive and inconvenient standard of care therapies. Our focus is to improve medications and ... qualcom stock price Aquestive Therapeutics Inc. 2.17. Delayed Data. As of May 19. +0.16 / +7.96%. Today’s Change. 0.62. Today ||| 52-Week Range. 2.65.Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ...Discover historical prices for AQST stock on Yahoo Finance. View daily, weekly or monthly format back to when Aquestive Therapeutics, Inc. stock was issued. Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... conversion of dollars to shekels What's Happening With Aquestive Therapeutics Inc Stock Today? Aquestive Therapeutics Inc (AQST) stock has fallen -4.72% while the S&P 500 is up 0.72% as of 12:38 PM on Wednesday, May 17. AQST has fallen -$0.10 from the previous closing price of $2.10 on volume of 402,790 shares. Over the past year the S&P 500 has risen 1.24% while AQST is up 65 ...Viracta Therapeutics Inc (VIRX) stock is up 10.49% while the S&P 500 is lower by -0.23% as of 3:14 PM on Friday, May 19. VIRX is up $0.20 from the previous closing price of $1.93 on volume of 1,354,358 shares. Over the past year the S&P 500 has risen 7.38% while VIRX is up 2.90%. VIRX lost -$1.34 per share the over the last 12 months. Click ...Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ...Discover historical prices for AQST stock on Yahoo Finance. View daily, weekly or monthly format back to when Aquestive Therapeutics, Inc. stock was issued. dragonfly linden Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ...May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. May 19, 2023 · A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. May 15, 2023 · Aquestive Therapeutics Inc ( AQST) is up 7.61% today. AQST has an Overall Score of 85. Find out what this means to you and get the rest of the rankings on AQST! AQST stock closed at $1.97 and is up $0.15 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between ... Discover historical prices for AQST stock on Yahoo Finance. View daily, weekly or monthly format back to when Aquestive Therapeutics, Inc. stock was issued. quik stock Aquestive Therapeutics Inc. 2.17. Delayed Data. As of May 19. +0.16 / +7.96%. Today’s Change. 0.62. Today ||| 52-Week Range. 2.65.To see how Aquestive Therapeutics Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: AQST stock’s … renata's crepes hobeesMay 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. Aquestive Therapeutics Inc (AQST) stock is trading at $2.38 as of 3:43 PM on Tuesday, May 23, a drop of -$0.03, or -1.25% from the previous closing price of $2.41. Volume today is high. So far 958,719 shares have traded compared to average volume of 698,928 shares. The stock has traded between $2.35 and $2.69 so far today. killen's burgers Volume today is high. So far 958,719 shares have traded compared to average volume of 698,928 shares. The stock has traded between $2.35 and $2.69 so far today. More About Aquestive Therapeutics Inc Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical ...May 19, 2023 · Viracta Therapeutics Inc (VIRX) stock is up 10.49% while the S&P 500 is lower by -0.23% as of 3:14 PM on Friday, May 19. VIRX is up $0.20 from the previous closing price of $1.93 on volume of 1,354,358 shares. Over the past year the S&P 500 has risen 7.38% while VIRX is up 2.90%. VIRX lost -$1.34 per share the over the last 12 months. Click ... bill.com stock priceAquestive Therapeutics, Inc. Common Stock (AQST) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Aquestive Therapeutics Inc (AQST) stock is trading at $2.38 as of 3:43 PM on Tuesday, May 23, a drop of -$0.03, or -1.25% from the previous closing price of $2.41. Volume today is high. So far 958,719 shares have traded compared to average volume of 698,928 shares. The stock has traded between $2.35 and $2.69 so far today.May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. May 19, 2023 · A high-level overview of Aquestive Therapeutics, Inc. (AQST) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. View Aquestive Therapeutics, Inc AQST investment & stock information. Get the latest Aquestive Therapeutics, Inc AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Aquestive Therapeutics Inc. 2.17. Delayed Data. As of May 19. +0.16 / +7.96%. Today’s Change. 0.62. Today ||| 52-Week Range. 2.65. todays most active stocks 2 days ago · Aquestive Therapeutics shares surged 6.7% in their trading debut Wednesday, after the company priced its initial public offering at $15 a share, the midpoint of its price range of $14 to $16. May 15, 2023 · Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... The Aquestive Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human …The latest price target for Aquestive Therapeutics ( NASDAQ: AQST) was reported by Wedbush on Thursday, March 9, 2023. The analyst firm set a price target for 4.00 expecting AQST to rise to within ... doordash stocks Miguel Garrison. May 9, 2023. Companies. Aquestive Therapeutics Inc. (NASDAQ:AQST) traded at $2.25 at close of the session on Monday, 05/08/23, made an upward move of 10.29% on its previous day’s price. Looking at the stock we see that its previous close was $2.04 with the day’s price range being $2.1296 – $2.40.May 19, 2023. $2.17. 720,545. 1:1. $1.99. $2.18. $1.92. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any …4 Wall Street analysts have issued 12-month target prices for Aquestive Therapeutics' stock. Their AQST share price forecasts range from $4.00 to $8.50. On average, they expect the company's share price to reach $6.13 in the next year. This suggests a possible upside of 154.1% from the stock's current price.May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. Autolus Therapeutics PLC (AUTL) stock is down -8.31% while the S&P 500 is higher by 0.43% as of 2:58 PM on Thursday, May 18. AUTL is lower by -$0.25 from the previous closing price of $2.95 on volume of 809,353 shares. Over the past year the S&P 500 is higher by 6.45% while AUTL is lower by -0.73%. how much is pounds in us dollars May 22, 2023 · What's Happening With Aquestive Therapeutics Inc Stock Today? Aquestive Therapeutics Inc (AQST) stock is trading at $2.44 as of 2:14 PM on Monday, May 22, an increase of $0.27, or 12.44% from the previous closing price of $2.17. The stock has traded between $2.15 and $2.45 so far today. Volume today is more active than usual. Autolus Therapeutics PLC (AUTL) stock is down -8.31% while the S&P 500 is higher by 0.43% as of 2:58 PM on Thursday, May 18. AUTL is lower by -$0.25 from the previous closing price of $2.95 on volume of 809,353 shares. Over the past year the S&P 500 is higher by 6.45% while AUTL is lower by -0.73%.To see how Aquestive Therapeutics Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: AQST stock’s performance was 7.83% at last check in today’s session, and 108.93% in the past year. Also during today’s trading, the S&P 500 Index has surged 0.09%, while the Dow Jones Industrial … greko greek street food By Katryna Perera. Law360 (March 15, 2023, 10:17 PM EDT) -- A New Jersey federal judge has dismissed for now a proposed investor class action against Aquestive Therapeutics Inc. that accused the pharmaceutical company and its executives of making false and misleading statements about the likelihood of the U.S. Food and Drug Administration approving one of its new drug applications. May 15, 2023 · Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ... The latest price target for Aquestive Therapeutics ( NASDAQ: AQST) was reported by Wedbush on Thursday, March 9, 2023. The analyst firm set a price target for 4.00 expecting AQST to rise to within ...2 days ago · View Aquestive Therapeutics, Inc AQST investment & stock information. Get the latest Aquestive Therapeutics, Inc AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. May 18, 2023 · Autolus Therapeutics PLC (AUTL) stock is down -8.31% while the S&P 500 is higher by 0.43% as of 2:58 PM on Thursday, May 18. AUTL is lower by -$0.25 from the previous closing price of $2.95 on volume of 809,353 shares. Over the past year the S&P 500 is higher by 6.45% while AUTL is lower by -0.73%. made by lilis Aquestive Therapeutics Inc (AQST) stock is trading at $2.38 as of 3:43 PM on Tuesday, May 23, a drop of -$0.03, or -1.25% from the previous closing price of …Aquestive is a pharmaceutical company aiming to solve patients’ problems by advancing current standards of care through simplifying complex delivery methods. Aquestive is developing orally administered products to provide novel alternatives to invasive and inconvenient standard of care therapies. Our focus is to improve medications and ...May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares. toro hibachiOut of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.View Aquestive Therapeutics, Inc AQST investment & stock information. Get the latest Aquestive Therapeutics, Inc AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Aquestive Therapeutics stock was originally listed at a price of $16.05 in Jul 25, 2018. If you had invested in Aquestive Therapeutics stock at $16.05, your return over the last 4 years would have been -87.23%, for an annualized return of -40.22% (not including any dividends or dividend reinvestments).720,545. 1:1. $1.99. $2.18. $1.92. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. pizza deliveries near me doordasAquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ...Aquestive Therapeutics Inc (AQST) stock is trading at $2.38 as of 3:43 PM on Tuesday, May 23, a drop of -$0.03, or -1.25% from the previous closing price of $2.41. Volume today is high. So far 958,719 shares have traded compared to average volume of 698,928 shares. The stock has traded between $2.35 and $2.69 so far today.Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.Aquestive Therapeutics shares surged 6.7% in their trading debut Wednesday, after the company priced its initial public offering at $15 a share, the midpoint of its price …2 days ago · Aquestive Therapeutics shares surged 6.7% in their trading debut Wednesday, after the company priced its initial public offering at $15 a share, the midpoint of its price range of $14 to $16. burger and brew 2 days ago · View Aquestive Therapeutics, Inc AQST investment & stock information. Get the latest Aquestive Therapeutics, Inc AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. To see how Aquestive Therapeutics Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: AQST stock’s performance was 7.83% at last check in today’s session, and 108.93% in the past year. Also during today’s trading, the S&P 500 Index has surged 0.09%, while the Dow Jones Industrial …Aquestive Therapeutics has an analyst consensus of Strong Buy, with a price target consensus of $5.58, which is a 183.25% upside from current levels. In a report released on May 12, JMP Securities ...Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.What is Aquestive Therapeutics Inc’s stock style? AQST’s stock style is Small Value. Style is an investment factor that has a meaningful impact on investment risk and returns.View Aquestive Therapeutics, Inc AQST investment & stock information. Get the latest Aquestive Therapeutics, Inc AQST detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.May 22, 2023 · Out of them, 0 rate it a Hold, while 6 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Aquestive Therapeutics Inc. (AQST) as Underweight, while 0 advise Sell. Analysts have rated the stock Buy, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.